Decreased mortality seen in rifampicin/multidrug-resistant tuberculous meningitis treated with linezolid in Shenzhen, China

BACKGROUND: The morbidity of rifampicin/multidrug-resistant tuberculous meningitis (RR/MDR-TBM) has shown an increasing trend globally. Its mortality rate is significantly higher than that of non-rifampicin/multidrug-resistant tuberculous meningitis (NRR/MDR-TBM). This article aimed to explore risk...

Descripción completa

Detalles Bibliográficos
Autores principales: Fang, Mu-Tong, Su, You-Feng, An, Hui-Ru, Zhang, Pei-Ze, Deng, Guo-Fang, Liu, Hou-Ming, Mao, Zhi, Zeng, Jian-Feng, Li, Guobao, Yang, Qian-Ting, Wang, Zhong-Yuan
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2021
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8480033/
https://www.ncbi.nlm.nih.gov/pubmed/34583653
http://dx.doi.org/10.1186/s12879-021-06705-4

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8480033/
https://www.ncbi.nlm.nih.gov/pubmed/34583653
http://dx.doi.org/10.1186/s12879-021-06705-4

Ejemplares similares